Commentary: the five Ws of a Fracture Liaison Service: why, who, what, where, and how? In osteoporosis, we reap what we sow.

Abstract:

:Establishing a Fracture Liaison Service (FLS) to identify and treat patients with a recent fragility fracture has been shown to be effective, save money, useful to document high quality of care, and makes good clinical sense. A FLS starts with an osteoporosis champion and encompasses identification of patients with a recent fracture, diagnostic workup, treatment, and follow-up. A FLS is most effective when it is able to function in multiple settings: the hospital, emergency department, and outpatient clinic. Implementation may be somewhat easier in a closed healthcare system but can be feasible even in an open system. There are many barriers to implementation which can be addressed. The future of FLS care lies in a collaborative systems-based approach with appropriate stakeholder engagement, leading to seamless integration of osteoporosis care.

journal_name

Curr Osteoporos Rep

authors

Curtis JR,Silverman SL

doi

10.1007/s11914-013-0177-9

subject

Has Abstract

pub_date

2013-12-01 00:00:00

pages

365-8

issue

4

eissn

1544-1873

issn

1544-2241

journal_volume

11

pub_type

杂志文章
  • Vitamin D Activity and Metabolism in Bone.

    abstract:PURPOSE OF REVIEW:In addition to the actions of the endocrine hormone, 1alpha,25-dihydroxyvitamin D (1,25(OH)2D) in stimulating intestinal calcium absorption, the regulation of bone mineral metabolism by 1,25(OH)2D is also considered an important contributor to calcium homeostasis. However, recent evidence suggest that...

    journal_title:Current osteoporosis reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11914-017-0394-8

    authors: Anderson PH

    更新日期:2017-10-01 00:00:00

  • Vitamin D and immune function: understanding common pathways.

    abstract::Vitamin D, acting through its active metabolite 1,25(OH)(2)D(3), exerts its influence on many physiologic processes in addition to the regulation of calcium and phosphate homeostasis. These processes include the immune system. Both the adaptive and innate immune systems are affected by 1,25(OH)(2)D(3) and its receptor...

    journal_title:Current osteoporosis reports

    pub_type: 杂志文章

    doi:10.1007/s11914-009-0011-6

    authors: Bikle DD

    更新日期:2009-07-01 00:00:00

  • Ex vivo Bone Models and Their Potential in Preclinical Evaluation.

    abstract:PURPOSE OF REVIEW:Novel therapies for damaged and diseased bone are being developed in a preclinical testing process consisting of in vitro cell experiments followed by in vivo animal studies. The in vitro results are often not representative of the results observed in vivo. This could be caused by the complexity of th...

    journal_title:Current osteoporosis reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11914-020-00649-5

    authors: Cramer EEA,Ito K,Hofmann S

    更新日期:2021-01-11 00:00:00

  • Statistical shape and appearance models in osteoporosis.

    abstract::Statistical models (SMs) of shape (SSM) and appearance (SAM) have been acquiring popularity in medical image analysis since they were introduced in the early 1990s. They have been primarily used for segmentation, but they are also a powerful tool for 3D reconstruction and classification. All these tasks may be require...

    journal_title:Current osteoporosis reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11914-014-0206-3

    authors: Castro-Mateos I,Pozo JM,Cootes TF,Wilkinson JM,Eastell R,Frangi AF

    更新日期:2014-06-01 00:00:00

  • Intercellular cross-talk among bone cells: new factors and pathways.

    abstract::Intercellular communication within the bone microenvironment is critical for the maintenance of normal bone structure. Osteoblast-lineage cells at all stages of differentiation, from pluripotent precursors to matrix-embedded osteocytes, produce regulatory factors that modulate the differentiation and activity of both ...

    journal_title:Current osteoporosis reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11914-012-0096-1

    authors: Sims NA,Walsh NC

    更新日期:2012-06-01 00:00:00

  • Romosozumab: a Review of Efficacy, Safety, and Cardiovascular Risk.

    abstract:PURPOSE OF REVIEW:Authors review the safety and efficacy of romosozumab for the treatment of osteoporosis as demonstrated in three phase III clinical trials and offer insights into the potential cardiovascular risk associated with its use. RECENT FINDINGS:Incidence of new vertebral fracture is dramatically reduced wit...

    journal_title:Current osteoporosis reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11914-020-00652-w

    authors: Fixen C,Tunoa J

    更新日期:2021-01-07 00:00:00

  • Biologicals in osteoporosis: teriparatide and parathyroid hormone in women and men.

    abstract::Osteoporosis is characterized by the occurrence of a host of fractures. According to densitometric values, an operational definition for osteoporosis corresponds to a loss of 25% to 30% (-2.5 T-scores) compared with the mean values of bone mineral density of young premenopausal women. For years, research tried to deve...

    journal_title:Current osteoporosis reports

    pub_type: 杂志文章

    doi:10.1007/s11914-010-0024-1

    authors: Devogelaer JP,Boutsen Y,Manicourt DH

    更新日期:2010-09-01 00:00:00

  • Inherited Arterial Calcification Syndromes: Etiologies and Treatment Concepts.

    abstract:PURPOSE OF REVIEW:We give an update on the etiology and potential treatment options of rare inherited monogenic disorders associated with arterial calcification and calcific cardiac valve disease. RECENT FINDINGS:Genetic studies of rare inherited syndromes have identified key regulators of ectopic calcification. Based...

    journal_title:Current osteoporosis reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11914-017-0370-3

    authors: Nitschke Y,Rutsch F

    更新日期:2017-08-01 00:00:00

  • Bone remodeling markers: assessment of fracture risk and fracture risk reduction.

    abstract::There is an increasing repertoire of laboratory tests available for assessing the bone remodeling process. Biochemical markers of bone remodeling can be measured in serum or urine, and have a number of potential roles in the management of fracture risk. Differences in remodeling between individuals might be related to...

    journal_title:Current osteoporosis reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11914-996-0002-9

    authors: Blumsohn A

    更新日期:2003-12-01 00:00:00

  • Osteoporosis treatment by a new active vitamin D3 compound, eldecalcitol, in Japan.

    abstract::Although vitamin D is used mainly as a nutritional supplement in osteoporosis treatment, its active form, 1,25-dihydroxyvitamin D [1,25(OH)(2)D], has an effect to maintain bone remodeling balance as well. Eldecalcitol is an analog of 1,25(OH) (2)D(3) with stronger effects than its native form in improving bone remodel...

    journal_title:Current osteoporosis reports

    pub_type: 杂志文章

    doi:10.1007/s11914-012-0116-1

    authors: Matsumoto T

    更新日期:2012-12-01 00:00:00

  • Quality Measures and Quality Improvement Initiatives in Osteoporosis-an Update.

    abstract:PURPOSE OF REVIEW:The aims of this review are to summarize current performance for osteoporosis quality measures used by Centers for Medicare and Medicaid (CMS) for pay-for-performance programs and to describe recent quality improvement strategies around these measures. RECENT FINDINGS:Healthcare Effectiveness Data an...

    journal_title:Current osteoporosis reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11914-019-00547-5

    authors: French S,Choden S,Schmajuk G

    更新日期:2019-12-01 00:00:00

  • Diabetes and Bone Marrow Adiposity.

    abstract:PURPOSE OF REVIEW:This study aims to describe bone marrow fat changes in diabetes and to discuss the potential role of marrow fat in skeletal fragility. RECENT FINDINGS:Advances in non-invasive imaging have facilitated marrow fat research in humans. In contrast to animal studies which clearly demonstrate higher levels...

    journal_title:Current osteoporosis reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11914-016-0336-x

    authors: Kim TY,Schafer AL

    更新日期:2016-12-01 00:00:00

  • Spaceflight-induced bone loss: is there an osteoporosis risk?

    abstract::Currently, the measurement of areal bone mineral density (aBMD) is used at NASA to evaluate the effects of spaceflight on the skeletal health of astronauts. Notably, there are precipitous declines in aBMD with losses >10 % detected in the hip and spine in some astronauts following a typical 6-month mission in space. H...

    journal_title:Current osteoporosis reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11914-013-0136-5

    authors: Sibonga JD

    更新日期:2013-06-01 00:00:00

  • Carbon Nanomaterials for Treating Osteoporotic Vertebral Fractures.

    abstract:PURPOSE OF REVIEW:To identify the use of carbon nanomaterials in bone regeneration and present new data on the regenerative capacity of bone tissue in osteopenic rats treated with graphene nanoribbons (GNRs). RECENT FINDINGS:The results show that the physical and chemical properties of the nanomaterials are suitable f...

    journal_title:Current osteoporosis reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11914-018-0476-2

    authors: de Carvalho JO,de Carvalho Oliveira F,Freitas SAP,Soares LM,de Cássia Barros Lima R,de Sousa Gonçalves L,Webster TJ,Marciano FR,Lobo AO

    更新日期:2018-10-01 00:00:00

  • Fracture Prediction by Computed Tomography and Finite Element Analysis: Current and Future Perspectives.

    abstract:PURPOSE OF REVIEW:This review critiques the ability of CT-based methods to predict incident hip and vertebral fractures. RECENT FINDINGS:CT-based techniques with concurrent calibration all show strong associations with incident hip and vertebral fracture, predicting hip and vertebral fractures as well as, and sometime...

    journal_title:Current osteoporosis reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11914-018-0450-z

    authors: Johannesdottir F,Allaire B,Bouxsein ML

    更新日期:2018-08-01 00:00:00

  • The RANKL/RANK/OPG pathway.

    abstract::Understanding of osteoclast formation and activation has advanced considerably since the discovery of the RANKL/RANK/OPG system in the mid 1990s. Osteoblasts and stromal stem cells express receptor activator of NF-jB ligand (RANKL), which binds to its receptor, RANK, on the surface of osteoclasts and their precursors....

    journal_title:Current osteoporosis reports

    pub_type: 杂志文章

    doi:10.1007/s11914-007-0024-y

    authors: Boyce BF,Xing L

    更新日期:2007-09-01 00:00:00

  • Glucocorticoid-Induced Osteoporosis: New Insights into the Pathophysiology and Treatments.

    abstract:PURPOSE OF THIS REVIEW:The goal of the review is to provide an updated understanding of the pathophysiology of glucocorticoid-induced osteoporosis and treatment recommendations. RECENT FINDINGS:Glucocorticoids reduce osteoblast and osteocyte lifespan and activity and reduce the vascularity of the bone that together ma...

    journal_title:Current osteoporosis reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11914-019-00498-x

    authors: Lane NE

    更新日期:2019-02-01 00:00:00

  • Monocyte Chemoattractant Protein-1 (MCP-1/CCL2) Drives Activation of Bone Remodelling and Skeletal Metastasis.

    abstract:PURPOSE OF REVIEW:The purpose of this review is to explore the role of monocyte chemoattractant protein-1 (MCP-1 or CCL2) in the processes that underpin bone remodelling, particularly the action of osteoblasts and osteoclasts, and its role in the development and metastasis of cancers that target the bone. RECENT FINDI...

    journal_title:Current osteoporosis reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11914-019-00545-7

    authors: Mulholland BS,Forwood MR,Morrison NA

    更新日期:2019-12-01 00:00:00

  • Parathyroid hormone and parathyroid hormone-related protein analogs as therapies for osteoporosis.

    abstract::Osteoporotic fractures result in significant morbidity and mortality. Anabolic agents reverse the negative skeletal balance that characterizes osteoporosis by stimulating osteoblast-dependent bone formation to a greater degree than osteoclast-dependent bone resorption. Parathyroid hormone (PTH) and parathyroid hormone...

    journal_title:Current osteoporosis reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11914-013-0171-2

    authors: Augustine M,Horwitz MJ

    更新日期:2013-12-01 00:00:00

  • The NPY system and its neural and neuroendocrine regulation of bone.

    abstract::The past decade has seen a significant expansion of our understanding of the interaction between the neural system and bone. While innervation of bone was long appreciated, the discovery of central relays from the hypothalamus to the cells of bone has seen the identification of a number of efferent neural pathways to ...

    journal_title:Current osteoporosis reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11914-012-0102-7

    authors: Khor EC,Baldock P

    更新日期:2012-06-01 00:00:00

  • Mouse Models of Frailty: an Emerging Field.

    abstract::Frailty is highly prevalent in the elderly, increasing the risk of poor outcomes that include falls, incident disability, hospitalization, and mortality. Thus, a great need exists to characterize the underlying mechanisms and ultimately identify strategies that prevent, delay, and even reverse frailty. Mouse models ca...

    journal_title:Current osteoporosis reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11914-015-0283-y

    authors: Seldeen KL,Pang M,Troen BR

    更新日期:2015-10-01 00:00:00

  • MicroRNA Exert Macro Effects on Cancer Bone Metastasis.

    abstract::Bone metastasis is a deadly complication of cancers arising from many different primary tumor locations. Cross talk between cancer and bone cells is a well-established driver of bone metastasis, and recent work reveals microRNA (miRNA) as key players in this communication. Functional significance of miRNA was first de...

    journal_title:Current osteoporosis reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11914-016-0316-1

    authors: Baier SR,Wan Y

    更新日期:2016-10-01 00:00:00

  • Bone density and markers of bone turnover in predicting fracture risk and how changes in these measures predict fracture risk reduction.

    abstract::Surrogate markers in clinical medicine provide a useful means to assess therapeutic response to pharmacologic therapy in a wide range of chronic disease states. In the area of osteoporosis, the surrogate markers of change in bone mineral density (BMD) and bone turnover markers (BTM) provide the clinician with a means ...

    journal_title:Current osteoporosis reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11914-005-0018-6

    authors: Miller PD

    更新日期:2005-09-01 00:00:00

  • Orthobiologics in the augmentation of osteoporotic fractures.

    abstract::Many orthobiologic adjuvants are available and widely utilized for general skeletal restoration. Their use for the specific task of osteoporotic fracture augmentation is less well recognized. Common conductive materials are reviewed for their value in this patient population including the large group of allograft adju...

    journal_title:Current osteoporosis reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11914-014-0249-5

    authors: Watson JT,Nicolaou DA

    更新日期:2015-02-01 00:00:00

  • New Insights in Understanding and Treating Bone Fracture Pain.

    abstract:PURPOSE OF REVIEW:This paper describes recent advances in understanding the mechanisms that drive fracture pain and how these findings are helping develop new therapies to treat fracture pain. RECENT FINDINGS:Immediately following fracture, mechanosensitive nerve fibers that innervate bone are mechanically distorted. ...

    journal_title:Current osteoporosis reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11914-018-0446-8

    authors: Mitchell SAT,Majuta LA,Mantyh PW

    更新日期:2018-08-01 00:00:00

  • Timing of subsequent fractures after an initial fracture.

    abstract::A prior fracture is a well-documented risk factor for a subsequent fracture and it doubles the risk of subsequent fractures. Few studies have investigated the time that elapses between the initial and subsequent fracture. These studies show that the subsequent fracture risk is not constant, but fluctuates over time. T...

    journal_title:Current osteoporosis reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11914-010-0023-2

    authors: van Geel TA,Huntjens KM,van den Bergh JP,Dinant GJ,Geusens PP

    更新日期:2010-09-01 00:00:00

  • RNA-seq in Skeletal Biology.

    abstract:PURPOSE OF REVIEW:The goal of this paper is to review state-of-the-art transcriptome profiling methods and their recent applications in the field of skeletal biology. RECENT FINDINGS:Next-generation sequencing of mRNA (RNA-seq) methods have been established and routinely used in skeletal biology research. RNA-seq has ...

    journal_title:Current osteoporosis reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11914-019-00517-x

    authors: Ayturk U

    更新日期:2019-08-01 00:00:00

  • Stem cell interactions in a bone marrow niche.

    abstract::Stem cells differ from other cells of the body in their potential for multilineage differentiation and their continued proliferation without substantial loss of potential (so-called self-renewal). These properties are maintained and regulated by a specific microenvironment referred to as "niche." This term has been us...

    journal_title:Current osteoporosis reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11914-011-0075-y

    authors: Isern J,Méndez-Ferrer S

    更新日期:2011-12-01 00:00:00

  • Endocrine crosstalk between muscle and bone.

    abstract::The musculoskeletal system is a complex organ comprised of the skeletal bones, skeletal muscles, tendons, ligaments, cartilage, joints, and other connective tissue that physically and mechanically interact to provide animals and humans with the essential ability of locomotion. This mechanical interaction is undoubtedl...

    journal_title:Current osteoporosis reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11914-014-0209-0

    authors: Brotto M,Johnson ML

    更新日期:2014-06-01 00:00:00

  • HIV infection and osteoporosis: pathophysiology, diagnosis, and treatment options.

    abstract::As the population with HIV continues to age, specialists in HIV care are increasingly encountering chronic health conditions, which now include osteoporosis, osteopenia, and fragility fractures. The pathophysiology of the bone effects of HIV infection is complex and includes traditional risk factors for bone loss as w...

    journal_title:Current osteoporosis reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11914-012-0125-0

    authors: Rothman MS,Bessesen MT

    更新日期:2012-12-01 00:00:00